CompletedPhase 2NCT00003661
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Roswell Park Cancer Institute
- Principal Investigator
- Barbara Jean Bambach, MDRoswell Park Cancer Institute
- Intervention
- anti-thymocyte globulin(biological)
- Enrollment
- 3 enrolled
- Eligibility
- 54 years · All sexes
- Timeline
- 1998 – 2006
Study locations (17)
- University of Florida Health Science Center, Gainesville, Florida, United States
- Division of Pediatric Surgery, Jacksonville, Florida, United States
- Nemours Children's Clinic, Jacksonville, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
- Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, United States
- University of Chicago Cancer Research Center, Chicago, Illinois, United States
- Children's Hospital of New Orleans, New Orleans, Louisiana, United States
- Cardinal Glennon Children's Hospital, St Louis, Missouri, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Roswell Park Cancer Institute, Buffalo, New York, United States
- North Shore University Hospital, Manhasset, New York, United States
- New York Blood Center, New York, New York, United States
- Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina, United States
- Duke Comprehensive Cancer Center, Durham, North Carolina, United States
- St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003661 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.